Recent Posts

Don’t be afraid of the eerie calm in US stocks

  Nir Kaissar There’s a strange disconnect today between some investors’ trepidation about US stocks and the soothing signals coming from the equity market. As my Bloomberg colleague Barry Ritholtz recently noted, a whole bunch of high-profile money mavens — Stan Druckenmiller, George Soros and Bill Gross included — are kvetching about the dangers lurking in U.S. shares (among other ...

Read More »

Concordia on the wrong side of pharma history

  Max Nisen Disappointing earnings. Substantially lower guidance for 2016. A CFO departure. A suspended dividend. A drug-pricing controversy. Oh, and a libel suit against a chicken farmer. All were features of Concordia International’s unusually calamitous earnings report on Friday. For a day, at least, the Ontario-based specialty pharma firm one-upped its better-known progenitor Valeant, which has had a mixed ...

Read More »

Phase-II of expansion of Al Ain Convention Centre launched

  Abu Dhabi / Emirates Business Abu Dhabi National Exhibitions Company (ADNEC), on Sunday announced the commencement of the second phase of expansion and development of Al Ain Convention Centre (AACC). The Phase II expansion work is in line with ADNEC’s strategy to promote and strengthen the high-potential business tourism industry in Al Ain. Aimed at enabling the exhibition and ...

Read More »
Send this to a friend